NextGen Omics US
The NextGen Omics US brings together leading omics experts from around the world.
Delegates can expect to benefit from discussions in the future of Next Generation Sequencing, Multi-omic Single Cell Analysis and Genome editing in Drug Discovery and Therapeutic Development.
Wednesday, March 30, 09:20 - 09:50 am (EDT)
CRISPR cell line development revolutionized:
Combining the power of CRISPR with FluidFM® to provide engineered cell lines as a service
Sensitive cells? Complex edits? High quality needed? We create the cell line for you.
Cytosurge provides you guaranteed monoclonal cell lines with high quality – even for hard-to-transfect and rare cells, complex edits like knock-in with large repair templates, or multiple knock-outs.
During the presentation of Dr. Tobias Beyer, our Chief Scientific Officer, you will learn more about our service enabled by our proprietary FluidFM® technology:
What is FluidFM and how can it be applied to cell line engineering
True single cell genome engineering: the power of the bottom-up approach
High quality monoclonal cell lines by reducing off-target editing and avoiding the tedious selection process
Customized design and consulting by our experts
Recent customer projects